These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36188629)

  • 21. Antiviral activity of a nanoemulsion of polyprenols from ginkgo leaves against influenza A H3N2 and hepatitis B virus in vitro.
    Wang CZ; Li WJ; Tao R; Ye JZ; Zhang HY
    Molecules; 2015 Mar; 20(3):5137-51. PubMed ID: 25808155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molnupiravir and Its Antiviral Activity Against COVID-19.
    Tian L; Pang Z; Li M; Lou F; An X; Zhu S; Song L; Tong Y; Fan H; Fan J
    Front Immunol; 2022; 13():855496. PubMed ID: 35444647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Taxonomic changes suggested by the genomic analysis of Hesperiidae (Lepidoptera).
    Zhang J; Cong Q; Shen J; Grishin NV
    Insecta mundi; 2022; 2022(921):. PubMed ID: 35370352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antiviral activity of extracts of basidiomycetes and humic compounds substances against Human Immunodeficiency Virus (Retroviridae: Orthoretrovirinae: Lentivirus: Human immunodeficiency virus 1) and Herpes Simplex Virus (Herpesviridae: Simplexvirus: Human alphaherpesvirus 1)].
    Nosik DN; Nosik NN; Teplyakova TV; Lobach OA; Kiseleva IA; Kondrashina NG; Bochkova MS; Ananko GG
    Vopr Virusol; 2020 Nov; 65(5):276-283. PubMed ID: 33533211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three new anti-HBV active constituents from the traditional Chinese herb of Yin-Chen (Artemisia scoparia).
    Geng CA; Huang XY; Chen XL; Ma YB; Rong GQ; Zhao Y; Zhang XM; Chen JJ
    J Ethnopharmacol; 2015 Dec; 176():109-17. PubMed ID: 26505294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Previously published ethno-pharmacological reports reveal the potentiality of plants and plant-derived products used as traditional home remedies by Bangladeshi COVID-19 patients to combat SARS-CoV-2.
    Rafiqul Islam ATM; Ferdousi J; Shahinozzaman M
    Saudi J Biol Sci; 2021 Nov; 28(11):6653-6673. PubMed ID: 34305428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promising Role of Emodin as Therapeutics to Against Viral Infections.
    Shao Q; Liu T; Wang W; Liu T; Jin X; Chen Z
    Front Pharmacol; 2022; 13():902626. PubMed ID: 35600857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triazavirin might be the new hope to fight Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Hudecová IMJČGKMPL
    Ceska Slov Farm; 2021; 70(1):18-25. PubMed ID: 34237949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
    Lvov DK; Alkhovsky SV
    Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antiviral drugs : Potent agents, promising therapies for COVID‑19 and therapeutic limitations].
    Malin JJ; Bunse T; Spinner CD; Protzer U
    Internist (Berl); 2022 Jan; 63(1):118-128. PubMed ID: 34988607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-hepatitis B virus effects of the traditional Chinese herb Artemisia capillaris and its active enynes.
    Geng CA; Yang TH; Huang XY; Yang J; Ma YB; Li TZ; Zhang XM; Chen JJ
    J Ethnopharmacol; 2018 Oct; 224():283-289. PubMed ID: 29890315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence, evolution, and vaccine production approaches of SARS-CoV-2 virus: Benefits of getting vaccinated and common questions.
    Hassanin AA; Haidar Abbas Raza S; Ahmed Ujjan J; Aysh ALrashidi A; Sitohy BM; Al-Surhanee AA; Saad AM; Mohamed Al-Hazani T; Osman Atallah O; Al Syaad KM; Ezzat Ahmed A; Swelum AA; El-Saadony MT; Sitohy MZ
    Saudi J Biol Sci; 2022 Apr; 29(4):1981-1997. PubMed ID: 34924802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.
    Díez-Fuertes F; Iglesias-Caballero M; García-Pérez J; Monzón S; Jiménez P; Varona S; Cuesta I; Zaballos Á; Jiménez M; Checa L; Pozo F; Pérez-Olmeda M; Thomson MM; Alcamí J; Casas I
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33127745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cirsimaritin inhibits influenza A virus replication by downregulating the NF-κB signal transduction pathway.
    Yan H; Wang H; Ma L; Ma X; Yin J; Wu S; Huang H; Li Y
    Virol J; 2018 May; 15(1):88. PubMed ID: 29783993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chloroplast genome sequences of Artemisia maritima and Artemisia absinthium: Comparative analyses, mutational hotspots in genus Artemisia and phylogeny in family Asteraceae.
    Shahzadi I; Abdullah ; Mehmood F; Ali Z; Ahmed I; Mirza B
    Genomics; 2020 Mar; 112(2):1454-1463. PubMed ID: 31450007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral and Immunomodulation Effects of Artemisia.
    Kshirsagar SG; Rao RV
    Medicina (Kaunas); 2021 Feb; 57(3):. PubMed ID: 33673527
    [No Abstract]   [Full Text] [Related]  

  • 37. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential Benefits of Antiviral African Medicinal Plants in the Management of Viral Infections: Systematic Review.
    Beressa TB; Deyno S; Mtewa AG; Aidah N; Tuyiringire N; Lukubye B; Weisheit A; Tolo CU; Ogwang PE
    Front Pharmacol; 2021; 12():682794. PubMed ID: 35002686
    [No Abstract]   [Full Text] [Related]  

  • 39. Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen.
    Heidary F; Gharebaghi R
    J Antibiot (Tokyo); 2020 Sep; 73(9):593-602. PubMed ID: 32533071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
    Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.